Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by L. Paré
De-Escalated Therapy for HR+/HER2+ Breast Cancer Patients With Ki67 Response After 2 Weeks Letrozole: Results of the PerELISA Neoadjuvant Study
Annals of Oncology
Medicine
Oncology
Hematology
Related publications
Erratum To: Tumor-Infiltrating Lymphocytes and Molecular Response After Neoadjuvant Therapy for HR+/HER2− Breast Cancer: Results From Two Prospective Trials
Breast Cancer Research and Treatment
Cancer Research
Oncology
Ki67 Measured After Neoadjuvant Chemotherapy for Primary Breast Cancer
Clinical Cancer Research
Cancer Research
Oncology
Relevance of Pathological Complete Response After Neoadjuvant Therapy for Breast Cancer
Breast Cancer: Basic and Clinical Research
Cancer Research
Oncology
Phase II Randomized Study of Ixabepilone Versus Observation in Patients With Significant Residual Disease After Neoadjuvant Systemic Therapy for HER2-Negative Breast Cancer
Clinical Breast Cancer
Cancer Research
Oncology
Ribociclib With Letrozole vs Letrozole Alone in Elderly Patients With Hormone Receptor-Positive, HER2-negative Breast Cancer in the Randomized MONALEESA-2 Trial
Breast Cancer Research and Treatment
Cancer Research
Oncology
Response to Neoadjuvant Therapy With Cisplatin in BRCA1-positive Breast Cancer Patients
Breast Cancer Research and Treatment
Cancer Research
Oncology
Everolimus-Based Therapy Versus Chemotherapy Among Patients With HR+/HER2− Metastatic Breast Cancer: Comparative Effectiveness From a Chart Review Study
International Journal of Breast Cancer
Cancer Research
Oncology
Pharmacology
18f-Fluorodeoxyglucose (FDG) PET/CT After Two Cycles of Neoadjuvant Therapy May Predict Response in HER2-negative, but Not in HER2-positive Breast Cancer
Oncotarget
Oncology
Pathologic Evaluation of Breast Cancer After Neoadjuvant Therapy
Journal of Pathology and Translational Medicine
Forensic Medicine
Pathology
Histology
